Higher MELD score increases the overall cost on the waiting list for liver transplantation: a micro-costing analysis based study

• Published in: Arquivos de gastroenterologia 2017-07, Vol.54 (3), p.238-245
• Main Authors: Turri, Jose Antonio Orellana, Decimoni, Tassia Cristina, Ferreira, Leandro Augusto, Diniz, Marcio Augusto, Haddad, Luciana Bertocco de Paiva, Campolina, Alessandro Gonçalves
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Avaliação em saúde; Cohort Studies; Custos e análise de custo; End Stage Liver Disease - economics; Female; GASTROENTEROLOGY & HEPATOLOGY; Health Care Costs - statistics & numerical data; Humans; Listas de espera; Liver Transplantation - economics; Male; Middle Aged; Severity of Illness Index; Transplante de fígado; Waiting Lists; Young Adult
• ISSN: 0004-2803; 1678-4219; 1678-4219
• DOI: 10.1590/S0004-2803.201700000-35

The pre-transplant period is complex and includes lots of procedures. The severity of liver disease predisposes to a high number of hospitalizations and high costs procedures. Economic evaluation studies are important tools to handle costs on the waiting list for liver transplantation. The objective of the present study was to evaluate the total cost of the patient on the waiting list for liver transplantation and the main resources related to higher costs. A cost study in a cohort of 482 patients registered on waiting list for liver transplantation was carried out. In 24 months follow-up, we evaluated all costs of materials, medicines, consultations, procedures, hospital admissions, laboratorial tests and image exams, hemocomponents replacements, and nutrition. The total amount of each resource or component used was aggregated and multiplied by the unitary cost, and thus individual cost for each patient was obtained. The total expenditure of the 482 patients was US$ 6,064,986.51. Outpatient and impatient costs correspond to 32.4% of total cost (US$ 1,965,045.52) and 67.6% (US$ 4,099,940.99) respectively. Main cost drivers in outpatient were: medicines (44.31%), laboratorial tests and image exams (31.68%). Main cost drivers regarding hospitalizations were: medicines (35.20%), bed use in ward and ICU (26.38%) and laboratorial tests (13.72%). Patients with MELD score between 25-30 were the most expensive on the waiting list (US$ 16,686.74 ± 16,105.02) and the less expensive were those with MELD below 17 (US$ 5,703.22 ± 9,318.68). Total costs on the waiting list for liver transplantation increased according to the patient's severity. Individually, hospitalizations, hemocomponents reposition and hepatocellular carcinoma treatment were the main cost drivers to the patient on the waiting list. The longer the waiting time, the higher the total cost on list, causing greater impact on health systems.